TERUMO YAMAGUCHI CORPORATIONMarch 30, 2023

FDA 483 - TERUMO YAMAGUCHI CORPORATION - March 30, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore TERUMO YAMAGUCHI CORPORATION

Record Details

TERUMO YAMAGUCHI CORPORATION, a sterile drug manufacturer in Yamaguchi, Japan, was cited with two observations during an FDA inspection. The inspection revealed deficiencies related to the sampling and testing of components for sterile drug products and issues with data integrity, specifically concerning the security and completeness of backup data for analytical equipment.

Company: TERUMO YAMAGUCHI CORPORATION
Inspection Date: March 30, 2023
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
People: Marcellinus D. Dordunoo (Investigator)
Melanie W. Pishnery

Open in Dashboard

ID · d47937e0-182b-47e6-a192-af22f0393f7f